Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: RETRACTED ARTICLE: Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout

Fig. 5

Skin irritation study in Sprague–Dawley rats, after dermal application (A), and Histopathological analysis (B) of 0.8% Formalin treated group, ALP-loaded NLCs gel treated group and untreated control group. Bar length shows 50 µm. Arrows and circles in 5A I represents erythema and edema, while in 5A II and III arrows represents absence of erythema and edema. Arrows in 5B I, shows dermal damage

Back to article page